MAGDA FRANCIS: Open Payments
NPI 1932546736 · HOBE SOUND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,676 in 18 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,676
Food & beverage: $1,676
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $335 |
| Gilead Sciences, Inc. | 2 | $260 |
| SANOFI-AVENTIS U.S. LLC | 2 | $247 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $145 |
| Axsome Therapeutics, Inc. | 1 | $122 |
| Alexion Pharmaceuticals, Inc. | 1 | $122 |
| ABIOMED | 1 | $121 |
| Actelion Pharmaceuticals US, Inc. | 1 | $116 |
| Alnylam Pharmaceuticals Inc. | 1 | $93 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $71 |
Products named: Wegovy, TZIELD, Biktarvy, Symbravo, ULTOMIRIS, UPTRAVI, Epclusa, AMVUTTRA.
Industry payments across FL — which companies pay providers there.
